First, AD was diagnosed only on the basis of clinical observation: the AD biomarker profile [CSF biomarkers (Aβ42, p-tau, and t-tau) or PET biomarkers (amyloid and tau PET)] of the participants was not available. Here, MAPT is linked to Alzheimer disease.